Health encyclopaedia - Alphabetical Topic List

| A | | B | | C | | D | | E | | F | | G | | H | | I | | J | | K | | L | | M |
| N | | O | | P | | Q | | R | | S | | T | | U | | V | | W | | X | | Y |

Treatment of Haemophilia

Factor VIII is a protein substance, a globulin. The substance can be isolated from donated blood and given to haemophiliacs to control their bleeding tendency. Unfortunately, factor VIII is active only for a short period – it loses half its activity after only 12 hours – so repeated injections are necessary.

The severity of haemophilia varies with the level of natural factor VIII activity in the individual. In severe cases the levels are less than five per cent of normal, and they may be less than two per cent of normal. The level of clotting-factor activity determines the need for replacement therapy, and the dosage. The replacement factors are given by slow injection into a vein.

Injections may be given on a regular basis, this helps prevent bleeding and minimise joint damage, or only when the bleeding occurs.A fairly recent development involves treatment is with genetically engineered factor VIII, ‘recombinant’ clotting factor, rather than donated human factor VIII.